相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes
Jihua Yang et al.
CANCER CELL INTERNATIONAL (2022)
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Chen Zhang et al.
MOLECULAR CANCER (2022)
Association of BRCA Mutations and Pancreatic Cancer
Saurabh Chandan et al.
PANCREAS (2022)
Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research
Zhenghai Bai et al.
BIOENGINEERED (2022)
Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer
Hillary G. Pratt et al.
CANCERS (2022)
Molecular Pathology of Pancreatic Cancer
Eva Karamitopoulou
CANCERS (2022)
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
Jindong Xie et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Krasmutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
Kanchan Singh et al.
LABORATORY INVESTIGATION (2021)
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Sophie Liot et al.
FRONTIERS IN IMMUNOLOGY (2021)
Metastatic renal cell carcinoma to pancreas and gastrointestinal tract: a clinicopathological study of 3 cases and review of literature
Jamshid Abdul-Ghafar et al.
BMC UROLOGY (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Christopher Nevala-Plagemann et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
Eric S Christenson et al.
LANCET ONCOLOGY (2020)
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
Julie Dardare et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel N. Hosein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB Technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines
Francesco Cellini et al.
CANCERS (2020)
Targeting MutantKRASin Pancreatic Cancer: Futile or Promising?
Friederike Inga Nollmann et al.
BIOMEDICINES (2020)
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Yunzhen Qian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
Robert H. Vonderheide et al.
FRONTIERS IN IMMUNOLOGY (2020)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Ashton A. Connor et al.
CANCER CELL (2019)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer
Andres Munoz Martin et al.
JOURNAL OF CANCER (2018)
ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
Sanchita Bhattacharya et al.
SCIENTIFIC DATA (2018)
B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
Peixin Dong et al.
FRONTIERS IN ONCOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Decision curve analysis: a technical note
Zhongheng Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Potential targeting of B7-H4 for the treatment of cancer
Joseph R. Podojil et al.
IMMUNOLOGICAL REVIEWS (2017)
Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective
Javier Perales-Paton et al.
PUBLIC HEALTH GENOMICS (2017)
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young-hee Lee et al.
CELL RESEARCH (2017)
Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target
Heather L. MacGregor et al.
CLINICAL CANCER RESEARCH (2017)
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Elodie Picarda et al.
CLINICAL CANCER RESEARCH (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
jvenn: an interactive Venn diagram viewer
Philippe Bardou et al.
BMC BIOINFORMATICS (2014)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
Paul Blanche et al.
STATISTICS IN MEDICINE (2013)
Pancreatic metastases from renal cell carcinoma: The state of the art
Roberto Ballarin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
CD8(+) tumor-infiltrating lymphocytes together with CD4(+) tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
A Fukunaga et al.
PANCREAS (2004)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
